100.00% -4.85

Genfit Adr (GNFT)

개요 뉴스 가격 이력 토론 예측

Genfit Adr 주식(GNFT)의 최신 뉴스

Nov 10, 2025

GENFIT signe un partenariat de recherche avec EVerZom pour faire progresser une technologie de médecine régénérative basée sur les exosomes dans l’ACLF - GlobeNewswire Inc.

Nov 10, 2025

Oct 30, 2025

GENFIT (NASDAQ:GNFT) Price Target Lowered to $7.00 at HC Wainwright - Defense World

Sep 25, 2025

Sep 24, 2025

HC Wainwright Has Lowered Expectations for GENFIT (NASDAQ:GNFT) Stock Price - MarketBeat

Sep 24, 2025

Jul 22, 2025

European ADRs Tick Up As Pharma And Telecom Lead Gains - Finimize

Jul 22, 2025

May 21, 2025

European ADRs Show Optimism As Genfit Leads Gains - Finimize

May 21, 2025

Apr 29, 2025

European ADRs Show Strength With Genfit And Novo Nordisk Leading Gains - Finimize

Apr 29, 2025

Apr 07, 2024

symbol__ Stock Quote Price and Forecast - CNN

Apr 07, 2024

Jun 30, 2023

Ipsen and GENFIT Announce Positive Results from Phase III ELATIVE trial of elafibranor in patients with primary biliary cholangitis, a rare cholestatic liver disease - Ipsen

Jun 30, 2023

Dec 17, 2021

Ipsen and GENFIT Enter Into Exclusive Licensing Agreement for Elafibranor, a Phase III Asset Evaluated in Primary Biliary Cholangitis, as Part of a Long-Term Global Partnership - Business Wire

Dec 17, 2021

Nov 11, 2020

GNFT Stock Price and Chart — EURONEXT:GNFT - TradingView

Nov 11, 2020

Nov 26, 2019

The Daily Biotech Pulse: ChemoCentryx Triples On Data Readout, Global Blood Given FDA Nod, Positive Safety Review For Genfit's NASH Drug - Yahoo Finance

Nov 26, 2019

Apr 03, 2019

Should I buy GENFIT (GNFT) - Zacks Investment Research

Apr 03, 2019

GNFT: GENFITFull Company Report - Zacks Investment Research

Apr 03, 2019

Oct 27, 2017

GNFT Stock Price | Genfit S.A. ADR Stock Quote (U.S.: Nasdaq) - MarketWatch

Oct 27, 2017

MRNA

$50.03

1.52%

ROIV

$27.84

0.51%

RPRX

$48.49

1.08%

BNTX

$89.42

0.61%

ONC

$308.44

3.86%

INSM

$164.86

0.82%

Genfit Adr (GNFT)

Genfit Adr 주식(GNFT)의 최신 뉴스

GENFIT signe un partenariat de recherche avec EVerZom pour faire progresser une technologie de médecine régénérative basée sur les exosomes dans l’ACLF - GlobeNewswire Inc.

GENFIT to Delist from Nasdaq, Focuses on Euronext Paris - TipRanks

European ADRs Start The Week With Small Gains Stateside - Finimize

FY2025 Earnings Estimate for GENFIT Issued By HC Wainwright - Defense World

HC Wainwright Has Pessimistic View of GENFIT FY2025 Earnings - MarketBeat

GENFIT (NASDAQ:GNFT) Price Target Lowered to $7.00 at HC Wainwright - Defense World

HC Wainwright Has Lowered Expectations for GENFIT (NASDAQ:GNFT) Stock Price - MarketBeat

European ADRs Tick Up As Pharma And Telecom Lead Gains - Finimize

European ADRs Show Optimism As Genfit Leads Gains - Finimize

European ADRs Show Strength With Genfit And Novo Nordisk Leading Gains - Finimize

symbol__ Stock Quote Price and Forecast - CNN

Ipsen and GENFIT Announce Positive Results from Phase III ELATIVE trial of elafibranor in patients with primary biliary cholangitis, a rare cholestatic liver disease - Ipsen

Ipsen and GENFIT Enter Into Exclusive Licensing Agreement for Elafibranor, a Phase III Asset Evaluated in Primary Biliary Cholangitis, as Part of a Long-Term Global Partnership - Business Wire

GNFT Stock Price and Chart — EURONEXT:GNFT - TradingView

The Daily Biotech Pulse: ChemoCentryx Triples On Data Readout, Global Blood Given FDA Nod, Positive Safety Review For Genfit's NASH Drug - Yahoo Finance

Should I buy GENFIT (GNFT) - Zacks Investment Research

GNFT: GENFITFull Company Report - Zacks Investment Research

GNFT Stock Price | Genfit S.A. ADR Stock Quote (U.S.: Nasdaq) - MarketWatch

GNFT과 유사한 종목